Celemics, Inc. (KOSDAQ:331920)

Market Cap	108.09B +349.6%
Revenue (ttm)	5.77B -14.2%
Net Income	-4.04B
EPS	-494.00
Shares Out	8.16M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	81,578
Average Volume	266,478
Open	13,330
Previous Close	13,330
Day's Range	13,070 - 14,100
52-Week Range	2,535 - 19,840
Beta	-0.36
RSI	44.04
Earnings Date	Apr 3, 2026

About Celemics

Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It also provides celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development se...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2010
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 331920